Series A funding round for Lysosomal Therapeutics raising $20M in February 2015
Series A funding round for Lysosomal Therapeutics raising $20M in February 2015
| Investor | Firm Type | Partner |
|---|
Atlas VentureLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Angel | Bob Carpenter | |
| Angel | Henri Termeer |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$25M
Top Valuation
-
Lysosomal Therapeutics raised $20M in a Series A round.
The round was announced on 02/01/15.
The round was led by Atlas Venture.